Everything is down biotech tech hospitality all sectors - it’s a macro direction based on inflation being up and likely interest rate changes pending to influence that inflation figure…
as Cane said the threat of a major military action is likely not helping.
over time Kazia will continue to outperform as we have all 8 trials rocketing forward and producing a heap of data - the substance is there and so will be the results.
it’s a shame that weaker hands are being shed at the moment but ultimately it’s a test of conviction - if you believe the remarkable results we seen thus far will play out in the final phase 3 GBM Agile trial then in reality it’s all a sideshow.
you will receive the reward you deserve.
